Skip to content

Drug interactions

Istradefylline + Tofacitinib

Severity: Moderate

Istradefylline and Tofacitinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

At 40 mg daily istradefylline raises exposure to CYP3A4 substrates, which may increase tofacitinib levels. This was not seen at 20 mg daily. The result could be more dose-related adverse effects of tofacitinib.

What this interaction means in plain words

Istradefylline and Tofacitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Istradefylline belongs to Central Nervous System; Tofacitinib belongs to Musculoskeletal.

Evidence level: Low

Why it happens

Istradefylline at higher doses inhibits CYP3A4, reducing tofacitinib clearance.

What to do

Monitor for tofacitinib adverse effects such as infection and cytopenias, particularly if istradefylline is given at 40 mg daily.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Istradefylline and Tofacitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Istradefylline with Tofacitinib?

MediHelp rates the interaction as moderate. Istradefylline and Tofacitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. At 40 mg daily istradefylline raises exposure to CYP3A4 substrates, which may increase tofacitinib levels. This was not seen at 20 mg daily. The result could be more dose-related adverse effects of tofacitinib.

How serious is the interaction between Istradefylline and Tofacitinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for tofacitinib adverse effects such as infection and cytopenias, particularly if istradefylline is given at 40 mg daily.

What other medicines interact with Tofacitinib?

MediHelp also lists interactions of Tofacitinib with, for example, Baricitinib, Cladribine, Upadacitinib. The full list is on the Tofacitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in